nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—EGFR—chronic obstructive pulmonary disease	0.475	1	CbGaD
Lapatinib—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0419	0.159	CbGbCtD
Lapatinib—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0419	0.159	CbGbCtD
Lapatinib—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0378	0.144	CbGbCtD
Lapatinib—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0267	0.101	CbGbCtD
Lapatinib—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.018	0.0686	CbGbCtD
Lapatinib—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0176	0.0668	CbGbCtD
Lapatinib—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0172	0.0654	CbGbCtD
Lapatinib—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0153	0.0583	CbGbCtD
Lapatinib—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.015	0.0571	CbGbCtD
Lapatinib—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0142	0.0539	CbGbCtD
Lapatinib—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.009	0.0342	CbGbCtD
Lapatinib—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0085	0.0323	CbGbCtD
Lapatinib—TAP1—bronchus—chronic obstructive pulmonary disease	0.00342	0.0748	CbGeAlD
Lapatinib—PIK3C2B—bronchus—chronic obstructive pulmonary disease	0.00321	0.0702	CbGeAlD
Lapatinib—TAP1—trachea—chronic obstructive pulmonary disease	0.00307	0.0671	CbGeAlD
Lapatinib—ERBB2—respiratory system—chronic obstructive pulmonary disease	0.00303	0.0663	CbGeAlD
Lapatinib—ERBB4—respiratory system—chronic obstructive pulmonary disease	0.00303	0.0663	CbGeAlD
Lapatinib—PIK3C2B—trachea—chronic obstructive pulmonary disease	0.00288	0.063	CbGeAlD
Lapatinib—PI4KB—respiratory system—chronic obstructive pulmonary disease	0.00284	0.0621	CbGeAlD
Lapatinib—ERBB2—connective tissue—chronic obstructive pulmonary disease	0.00267	0.0584	CbGeAlD
Lapatinib—Gefitinib—ERBB3—chronic obstructive pulmonary disease	0.00258	0.541	CrCbGaD
Lapatinib—ERBB2—Theophylline—Aminophylline—chronic obstructive pulmonary disease	0.00246	0.45	CbGdCrCtD
Lapatinib—ERBB2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00244	0.0534	CbGeAlD
Lapatinib—PI4KB—bronchus—chronic obstructive pulmonary disease	0.00234	0.0511	CbGeAlD
Lapatinib—PI4KB—smooth muscle tissue—chronic obstructive pulmonary disease	0.00229	0.05	CbGeAlD
Lapatinib—TAP1—lung—chronic obstructive pulmonary disease	0.0022	0.0482	CbGeAlD
Lapatinib—PI4KB—trachea—chronic obstructive pulmonary disease	0.0021	0.0459	CbGeAlD
Lapatinib—PIK3C2B—lung—chronic obstructive pulmonary disease	0.00207	0.0453	CbGeAlD
Lapatinib—ERBB2—lung—chronic obstructive pulmonary disease	0.00161	0.0352	CbGeAlD
Lapatinib—ERBB4—lung—chronic obstructive pulmonary disease	0.00161	0.0352	CbGeAlD
Lapatinib—PI4KB—lung—chronic obstructive pulmonary disease	0.00151	0.033	CbGeAlD
Lapatinib—EGFR—lung—chronic obstructive pulmonary disease	0.00136	0.0299	CbGeAlD
Lapatinib—Gefitinib—EGFR—chronic obstructive pulmonary disease	0.00116	0.243	CrCbGaD
Lapatinib—ERBB2—Arformoterol—Formoterol—chronic obstructive pulmonary disease	0.000904	0.165	CbGdCrCtD
Lapatinib—ERBB2—Formoterol—Arformoterol—chronic obstructive pulmonary disease	0.000904	0.165	CbGdCrCtD
Lapatinib—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000743	0.0163	CbGeAlD
Lapatinib—Gefitinib—CYP1A1—chronic obstructive pulmonary disease	0.000661	0.139	CrCbGaD
Lapatinib—PIK3C2B—Epinephrine—Salbutamol—chronic obstructive pulmonary disease	0.000583	0.107	CbGdCrCtD
Lapatinib—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000581	0.0056	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000577	0.00556	CcSEcCtD
Lapatinib—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000576	0.00555	CcSEcCtD
Lapatinib—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000571	0.00551	CcSEcCtD
Lapatinib—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000554	0.00534	CcSEcCtD
Lapatinib—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000546	0.00527	CcSEcCtD
Lapatinib—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000537	0.00517	CcSEcCtD
Lapatinib—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000534	0.00515	CcSEcCtD
Lapatinib—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000533	0.00514	CcSEcCtD
Lapatinib—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000528	0.00509	CcSEcCtD
Lapatinib—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.000524	0.00505	CcSEcCtD
Lapatinib—Infestation—Montelukast—chronic obstructive pulmonary disease	0.000521	0.00502	CcSEcCtD
Lapatinib—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.000521	0.00502	CcSEcCtD
Lapatinib—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000518	0.00499	CcSEcCtD
Lapatinib—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000515	0.00496	CcSEcCtD
Lapatinib—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.000511	0.00492	CcSEcCtD
Lapatinib—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000498	0.0048	CcSEcCtD
Lapatinib—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000493	0.00475	CcSEcCtD
Lapatinib—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000492	0.00474	CcSEcCtD
Lapatinib—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.000492	0.00474	CcSEcCtD
Lapatinib—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000491	0.00473	CcSEcCtD
Lapatinib—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.00472	CcSEcCtD
Lapatinib—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000483	0.00465	CcSEcCtD
Lapatinib—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000479	0.00462	CcSEcCtD
Lapatinib—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000474	0.00456	CcSEcCtD
Lapatinib—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000469	0.00452	CcSEcCtD
Lapatinib—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000469	0.00452	CcSEcCtD
Lapatinib—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00046	0.00443	CcSEcCtD
Lapatinib—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000457	0.00441	CcSEcCtD
Lapatinib—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000455	0.00439	CcSEcCtD
Lapatinib—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000449	0.00433	CcSEcCtD
Lapatinib—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000446	0.00429	CcSEcCtD
Lapatinib—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000443	0.00427	CcSEcCtD
Lapatinib—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000443	0.00427	CcSEcCtD
Lapatinib—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000443	0.00427	CcSEcCtD
Lapatinib—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000443	0.00427	CcSEcCtD
Lapatinib—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000438	0.00422	CcSEcCtD
Lapatinib—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000438	0.00422	CcSEcCtD
Lapatinib—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000437	0.00421	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000435	0.0042	CcSEcCtD
Lapatinib—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000434	0.00418	CcSEcCtD
Lapatinib—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000431	0.00416	CcSEcCtD
Lapatinib—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000431	0.00416	CcSEcCtD
Lapatinib—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00043	0.00415	CcSEcCtD
Lapatinib—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00043	0.00415	CcSEcCtD
Lapatinib—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000425	0.00409	CcSEcCtD
Lapatinib—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000425	0.00409	CcSEcCtD
Lapatinib—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000422	0.00407	CcSEcCtD
Lapatinib—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000421	0.00406	CcSEcCtD
Lapatinib—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000421	0.00406	CcSEcCtD
Lapatinib—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000421	0.00406	CcSEcCtD
Lapatinib—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000419	0.00403	CcSEcCtD
Lapatinib—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000418	0.00403	CcSEcCtD
Lapatinib—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000418	0.00403	CcSEcCtD
Lapatinib—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000418	0.00403	CcSEcCtD
Lapatinib—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000418	0.00402	CcSEcCtD
Lapatinib—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.004	CcSEcCtD
Lapatinib—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000416	0.004	CcSEcCtD
Lapatinib—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000412	0.00397	CcSEcCtD
Lapatinib—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00041	0.00395	CcSEcCtD
Lapatinib—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.00394	CcSEcCtD
Lapatinib—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000408	0.00393	CcSEcCtD
Lapatinib—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000407	0.00392	CcSEcCtD
Lapatinib—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000406	0.00391	CcSEcCtD
Lapatinib—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000403	0.00388	CcSEcCtD
Lapatinib—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.00387	CcSEcCtD
Lapatinib—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000402	0.00387	CcSEcCtD
Lapatinib—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000397	0.00383	CcSEcCtD
Lapatinib—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00381	CcSEcCtD
Lapatinib—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000395	0.00864	CbGeAlD
Lapatinib—CYP3A5—lung—chronic obstructive pulmonary disease	0.000395	0.00864	CbGeAlD
Lapatinib—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.00378	CcSEcCtD
Lapatinib—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000392	0.00378	CcSEcCtD
Lapatinib—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000387	0.00373	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000383	0.00369	CcSEcCtD
Lapatinib—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00038	0.00366	CcSEcCtD
Lapatinib—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00366	CcSEcCtD
Lapatinib—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00037	0.00356	CcSEcCtD
Lapatinib—Gefitinib—ALB—chronic obstructive pulmonary disease	0.000368	0.0773	CrCbGaD
Lapatinib—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000367	0.00354	CcSEcCtD
Lapatinib—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000367	0.00354	CcSEcCtD
Lapatinib—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000364	0.00351	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000363	0.0035	CcSEcCtD
Lapatinib—Cough—Formoterol—chronic obstructive pulmonary disease	0.000363	0.00349	CcSEcCtD
Lapatinib—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.00349	CcSEcCtD
Lapatinib—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00036	0.00347	CcSEcCtD
Lapatinib—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000359	0.00346	CcSEcCtD
Lapatinib—Cough—Montelukast—chronic obstructive pulmonary disease	0.000355	0.00342	CcSEcCtD
Lapatinib—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000354	0.00341	CcSEcCtD
Lapatinib—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000354	0.00341	CcSEcCtD
Lapatinib—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000354	0.00341	CcSEcCtD
Lapatinib—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000354	0.00341	CcSEcCtD
Lapatinib—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000352	0.00339	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.00339	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000351	0.00339	CcSEcCtD
Lapatinib—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000347	0.00334	CcSEcCtD
Lapatinib—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000347	0.00334	CcSEcCtD
Lapatinib—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000347	0.00334	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000344	0.00332	CcSEcCtD
Lapatinib—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000344	0.00331	CcSEcCtD
Lapatinib—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000343	0.0033	CcSEcCtD
Lapatinib—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.0033	CcSEcCtD
Lapatinib—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.00327	CcSEcCtD
Lapatinib—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000339	0.00327	CcSEcCtD
Lapatinib—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000337	0.00325	CcSEcCtD
Lapatinib—Infection—Formoterol—chronic obstructive pulmonary disease	0.000337	0.00325	CcSEcCtD
Lapatinib—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00322	CcSEcCtD
Lapatinib—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00322	CcSEcCtD
Lapatinib—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.00321	CcSEcCtD
Lapatinib—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000333	0.00321	CcSEcCtD
Lapatinib—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000332	0.0032	CcSEcCtD
Lapatinib—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000332	0.0032	CcSEcCtD
Lapatinib—Infection—Montelukast—chronic obstructive pulmonary disease	0.00033	0.00318	CcSEcCtD
Lapatinib—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000329	0.00317	CcSEcCtD
Lapatinib—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.00317	CcSEcCtD
Lapatinib—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000328	0.00316	CcSEcCtD
Lapatinib—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000326	0.00314	CcSEcCtD
Lapatinib—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000323	0.00311	CcSEcCtD
Lapatinib—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00309	CcSEcCtD
Lapatinib—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.00307	CcSEcCtD
Lapatinib—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000315	0.00304	CcSEcCtD
Lapatinib—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00303	CcSEcCtD
Lapatinib—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.003	CcSEcCtD
Lapatinib—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00031	0.00298	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00298	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00298	CcSEcCtD
Lapatinib—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.00296	CcSEcCtD
Lapatinib—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000307	0.00296	CcSEcCtD
Lapatinib—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00294	CcSEcCtD
Lapatinib—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000305	0.00294	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000303	0.00292	CcSEcCtD
Lapatinib—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000302	0.00291	CcSEcCtD
Lapatinib—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.00291	CcSEcCtD
Lapatinib—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.0003	0.0029	CcSEcCtD
Lapatinib—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000299	0.00288	CcSEcCtD
Lapatinib—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000299	0.00288	CcSEcCtD
Lapatinib—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000297	0.00287	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000293	0.00282	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000293	0.00282	CcSEcCtD
Lapatinib—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000292	0.00282	CcSEcCtD
Lapatinib—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000292	0.00282	CcSEcCtD
Lapatinib—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000292	0.00282	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00281	CcSEcCtD
Lapatinib—ABCB1—trachea—chronic obstructive pulmonary disease	0.000292	0.00639	CbGeAlD
Lapatinib—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00029	0.00279	CcSEcCtD
Lapatinib—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00029	0.00279	CcSEcCtD
Lapatinib—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.00279	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000287	0.00276	CcSEcCtD
Lapatinib—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000286	0.00276	CcSEcCtD
Lapatinib—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00275	CcSEcCtD
Lapatinib—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000283	0.00273	CcSEcCtD
Lapatinib—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000282	0.00272	CcSEcCtD
Lapatinib—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00272	CcSEcCtD
Lapatinib—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000281	0.00271	CcSEcCtD
Lapatinib—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000281	0.00271	CcSEcCtD
Lapatinib—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000279	0.00269	CcSEcCtD
Lapatinib—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00268	CcSEcCtD
Lapatinib—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000278	0.00268	CcSEcCtD
Lapatinib—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.00267	CcSEcCtD
Lapatinib—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000277	0.00267	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00266	CcSEcCtD
Lapatinib—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00266	CcSEcCtD
Lapatinib—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.00264	CcSEcCtD
Lapatinib—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000272	0.00262	CcSEcCtD
Lapatinib—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000268	0.00258	CcSEcCtD
Lapatinib—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000268	0.00258	CcSEcCtD
Lapatinib—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000267	0.00257	CcSEcCtD
Lapatinib—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000265	0.00255	CcSEcCtD
Lapatinib—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000265	0.00255	CcSEcCtD
Lapatinib—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000265	0.00255	CcSEcCtD
Lapatinib—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000263	0.00254	CcSEcCtD
Lapatinib—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000263	0.00253	CcSEcCtD
Lapatinib—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00252	CcSEcCtD
Lapatinib—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.00244	CcSEcCtD
Lapatinib—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00241	CcSEcCtD
Lapatinib—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00241	CcSEcCtD
Lapatinib—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00025	0.00241	CcSEcCtD
Lapatinib—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000249	0.0024	CcSEcCtD
Lapatinib—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000245	0.00236	CcSEcCtD
Lapatinib—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00234	CcSEcCtD
Lapatinib—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00234	CcSEcCtD
Lapatinib—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00024	0.00231	CcSEcCtD
Lapatinib—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.00231	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00231	CcSEcCtD
Lapatinib—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000238	0.0023	CcSEcCtD
Lapatinib—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00227	CcSEcCtD
Lapatinib—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000235	0.00226	CcSEcCtD
Lapatinib—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000232	0.00224	CcSEcCtD
Lapatinib—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.00224	CcSEcCtD
Lapatinib—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00221	CcSEcCtD
Lapatinib—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000227	0.00219	CcSEcCtD
Lapatinib—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00218	CcSEcCtD
Lapatinib—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00212	CcSEcCtD
Lapatinib—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00211	CcSEcCtD
Lapatinib—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00208	CcSEcCtD
Lapatinib—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00208	CcSEcCtD
Lapatinib—Rash—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00206	CcSEcCtD
Lapatinib—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00206	CcSEcCtD
Lapatinib—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00206	CcSEcCtD
Lapatinib—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00206	CcSEcCtD
Lapatinib—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00205	CcSEcCtD
Lapatinib—Headache—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00205	CcSEcCtD
Lapatinib—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000211	0.00204	CcSEcCtD
Lapatinib—ABCB1—lung—chronic obstructive pulmonary disease	0.00021	0.00459	CbGeAlD
Lapatinib—Rash—Montelukast—chronic obstructive pulmonary disease	0.000209	0.00202	CcSEcCtD
Lapatinib—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000209	0.00202	CcSEcCtD
Lapatinib—Headache—Montelukast—chronic obstructive pulmonary disease	0.000208	0.00201	CcSEcCtD
Lapatinib—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00198	CcSEcCtD
Lapatinib—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00196	CcSEcCtD
Lapatinib—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00195	CcSEcCtD
Lapatinib—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00194	CcSEcCtD
Lapatinib—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00194	CcSEcCtD
Lapatinib—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00194	CcSEcCtD
Lapatinib—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00193	CcSEcCtD
Lapatinib—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000197	0.0019	CcSEcCtD
Lapatinib—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00183	CcSEcCtD
Lapatinib—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00178	CcSEcCtD
Lapatinib—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.00177	CcSEcCtD
Lapatinib—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00164	CcSEcCtD
Lapatinib—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00164	CcSEcCtD
Lapatinib—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.0016	CcSEcCtD
Lapatinib—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000166	0.0016	CcSEcCtD
Lapatinib—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00159	CcSEcCtD
Lapatinib—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000164	0.00158	CcSEcCtD
Lapatinib—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00146	CcSEcCtD
Lapatinib—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00134	CcSEcCtD
Lapatinib—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00134	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00133	CcSEcCtD
Lapatinib—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.0013	CcSEcCtD
Lapatinib—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00129	CcSEcCtD
Lapatinib—Infection—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00128	CcSEcCtD
Lapatinib—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00126	CcSEcCtD
Lapatinib—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00125	CcSEcCtD
Lapatinib—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00123	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00117	CcSEcCtD
Lapatinib—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00116	CcSEcCtD
Lapatinib—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00113	CcSEcCtD
Lapatinib—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00112	CcSEcCtD
Lapatinib—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.00112	CcSEcCtD
Lapatinib—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.00112	CcSEcCtD
Lapatinib—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00111	CcSEcCtD
Lapatinib—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.00111	CcSEcCtD
Lapatinib—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000114	0.0011	CcSEcCtD
Lapatinib—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00105	CcSEcCtD
Lapatinib—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.00105	CcSEcCtD
Lapatinib—PIK3C2B—Exemestane—Prednisone—chronic obstructive pulmonary disease	0.000106	0.0195	CbGdCrCtD
Lapatinib—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000106	0.00102	CcSEcCtD
Lapatinib—PIK3C2B—Exemestane—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.019	CbGdCrCtD
Lapatinib—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.83e-05	0.000948	CcSEcCtD
Lapatinib—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.58e-05	0.000923	CcSEcCtD
Lapatinib—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.44e-05	0.00091	CcSEcCtD
Lapatinib—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.13e-05	0.00088	CcSEcCtD
Lapatinib—ERBB2—Exemestane—Prednisone—chronic obstructive pulmonary disease	8.76e-05	0.016	CbGdCrCtD
Lapatinib—ERBB2—Exemestane—Prednisolone—chronic obstructive pulmonary disease	8.55e-05	0.0156	CbGdCrCtD
Lapatinib—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.000818	CcSEcCtD
Lapatinib—Rash—Prednisone—chronic obstructive pulmonary disease	8.42e-05	0.000811	CcSEcCtD
Lapatinib—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.00081	CcSEcCtD
Lapatinib—Headache—Prednisone—chronic obstructive pulmonary disease	8.36e-05	0.000806	CcSEcCtD
Lapatinib—Nausea—Prednisone—chronic obstructive pulmonary disease	7.93e-05	0.000764	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	4.77e-05	0.00873	CbGdCrCtD
Lapatinib—ERBB2—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	4.66e-05	0.00852	CbGdCrCtD
Lapatinib—ERBB2—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	4.53e-05	0.00829	CbGdCrCtD
Lapatinib—PIK3C2B—Danazol—Prednisone—chronic obstructive pulmonary disease	4.49e-05	0.00821	CbGdCrCtD
Lapatinib—ERBB2—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	4.43e-05	0.0081	CbGdCrCtD
Lapatinib—ERBB2—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.44e-05	0.000336	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.41e-05	0.000334	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—IL6—chronic obstructive pulmonary disease	3.3e-05	0.000323	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.3e-05	0.000323	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—ERBB3—chronic obstructive pulmonary disease	3.29e-05	0.000321	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.26e-05	0.000319	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—IL6—chronic obstructive pulmonary disease	3.25e-05	0.000318	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	3.24e-05	0.000317	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	3.24e-05	0.000317	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—ERBB3—chronic obstructive pulmonary disease	3.24e-05	0.000316	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—VEGFA—chronic obstructive pulmonary disease	3.2e-05	0.000313	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.19e-05	0.000312	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.17e-05	0.00031	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.13e-05	0.000306	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—TP53—chronic obstructive pulmonary disease	3.09e-05	0.000302	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.09e-05	0.000302	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.08e-05	0.000301	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.05e-05	0.000298	CbGpPWpGaD
Lapatinib—ERBB2—Disease—ERBB3—chronic obstructive pulmonary disease	3.03e-05	0.000297	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TNF—chronic obstructive pulmonary disease	3.03e-05	0.000296	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.01e-05	0.000294	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CRP—chronic obstructive pulmonary disease	3e-05	0.000294	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3e-05	0.000294	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	2.99e-05	0.000293	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—IL6—chronic obstructive pulmonary disease	2.99e-05	0.000292	CbGpPWpGaD
Lapatinib—ERBB4—Disease—ERBB3—chronic obstructive pulmonary disease	2.99e-05	0.000292	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CRP—chronic obstructive pulmonary disease	2.96e-05	0.000289	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.93e-05	0.000286	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IL6—chronic obstructive pulmonary disease	2.92e-05	0.000286	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.91e-05	0.000284	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—TLR4—chronic obstructive pulmonary disease	2.88e-05	0.000282	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—TLR4—chronic obstructive pulmonary disease	2.84e-05	0.000277	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.83e-05	0.000277	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.83e-05	0.000277	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	2.82e-05	0.000275	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	2.81e-05	0.000275	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.8e-05	0.000273	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.79e-05	0.000273	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.78e-05	0.000271	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—LEP—chronic obstructive pulmonary disease	2.76e-05	0.00027	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.73e-05	0.000267	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	2.73e-05	0.000267	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—IL6—chronic obstructive pulmonary disease	2.69e-05	0.000263	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	2.67e-05	0.000261	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	2.65e-05	0.000259	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.64e-05	0.000258	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.64e-05	0.000258	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.64e-05	0.000258	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	2.62e-05	0.000256	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.62e-05	0.000256	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.61e-05	0.000255	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.58e-05	0.000252	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.57e-05	0.000251	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NOS2—chronic obstructive pulmonary disease	2.53e-05	0.000247	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	2.53e-05	0.000247	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	2.52e-05	0.000246	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	2.5e-05	0.000245	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.5e-05	0.000244	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CRP—chronic obstructive pulmonary disease	2.49e-05	0.000244	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—IL6—chronic obstructive pulmonary disease	2.49e-05	0.000244	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NOS2—chronic obstructive pulmonary disease	2.49e-05	0.000244	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.46e-05	0.000241	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—EGFR—chronic obstructive pulmonary disease	2.45e-05	0.00024	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.43e-05	0.000237	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—EGFR—chronic obstructive pulmonary disease	2.42e-05	0.000236	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.41e-05	0.000236	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.4e-05	0.000234	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—TLR4—chronic obstructive pulmonary disease	2.39e-05	0.000234	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.39e-05	0.000233	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	2.35e-05	0.00023	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	2.34e-05	0.000229	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	2.34e-05	0.000229	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—IL6—chronic obstructive pulmonary disease	2.34e-05	0.000229	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.34e-05	0.000229	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—MMP9—chronic obstructive pulmonary disease	2.33e-05	0.000228	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	2.32e-05	0.000227	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	2.32e-05	0.000227	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	2.3e-05	0.000225	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.3e-05	0.000225	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.3e-05	0.000225	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	2.29e-05	0.000224	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.29e-05	0.000224	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.27e-05	0.000222	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.27e-05	0.000222	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TLR2—chronic obstructive pulmonary disease	2.25e-05	0.00022	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.22e-05	0.000217	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.2e-05	0.000215	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.14e-05	0.000209	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.13e-05	0.000209	CbGpPWpGaD
Lapatinib—ERBB2—Disease—SERPINE1—chronic obstructive pulmonary disease	2.13e-05	0.000208	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.12e-05	0.000208	CbGpPWpGaD
Lapatinib—EGFR—Immune System—KL—chronic obstructive pulmonary disease	2.12e-05	0.000207	CbGpPWpGaD
Lapatinib—EGFR—Disease—HDAC2—chronic obstructive pulmonary disease	2.1e-05	0.000206	CbGpPWpGaD
Lapatinib—ERBB4—Disease—SERPINE1—chronic obstructive pulmonary disease	2.1e-05	0.000205	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.09e-05	0.000205	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—VEGFA—chronic obstructive pulmonary disease	2.09e-05	0.000204	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	2.08e-05	0.000203	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.07e-05	0.000202	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.04e-05	0.0002	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.04e-05	0.000199	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NOS3—chronic obstructive pulmonary disease	2.03e-05	0.000199	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.02e-05	0.000198	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.02e-05	0.000197	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.01e-05	0.000197	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.01e-05	0.000196	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NOS3—chronic obstructive pulmonary disease	2e-05	0.000196	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.99e-05	0.000195	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.99e-05	0.000194	CbGpPWpGaD
Lapatinib—EGFR—Disease—KL—chronic obstructive pulmonary disease	1.96e-05	0.000191	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.94e-05	0.000189	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.91e-05	0.000187	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.9e-05	0.000186	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.88e-05	0.000184	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL1B—chronic obstructive pulmonary disease	1.87e-05	0.000183	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.87e-05	0.000183	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.86e-05	0.000181	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.85e-05	0.000181	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL1B—chronic obstructive pulmonary disease	1.85e-05	0.00018	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.85e-05	0.00018	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.8e-05	0.000176	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD8A—chronic obstructive pulmonary disease	1.71e-05	0.000167	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.67e-05	0.000164	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.66e-05	0.000162	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.65e-05	0.000161	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.61e-05	0.000157	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—IL6—chronic obstructive pulmonary disease	1.6e-05	0.000156	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ERBB3—chronic obstructive pulmonary disease	1.59e-05	0.000155	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.55e-05	0.000151	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.49e-05	0.000146	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.49e-05	0.000146	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.48e-05	0.000144	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.47e-05	0.000144	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.47e-05	0.000144	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.47e-05	0.000144	CbGpPWpGaD
Lapatinib—EGFR—Disease—ERBB3—chronic obstructive pulmonary disease	1.47e-05	0.000143	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CRP—chronic obstructive pulmonary disease	1.45e-05	0.000142	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.45e-05	0.000142	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—IL6—chronic obstructive pulmonary disease	1.45e-05	0.000141	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—EGFR—chronic obstructive pulmonary disease	1.43e-05	0.00014	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.42e-05	0.000139	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—EGFR—chronic obstructive pulmonary disease	1.41e-05	0.000138	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.4e-05	0.000137	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.4e-05	0.000137	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TLR4—chronic obstructive pulmonary disease	1.39e-05	0.000136	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.39e-05	0.000136	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.38e-05	0.000135	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.37e-05	0.000134	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.37e-05	0.000134	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TGFB1—chronic obstructive pulmonary disease	1.34e-05	0.000131	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TGFB1—chronic obstructive pulmonary disease	1.32e-05	0.000129	CbGpPWpGaD
Lapatinib—ERBB2—Disease—EGFR—chronic obstructive pulmonary disease	1.32e-05	0.000129	CbGpPWpGaD
Lapatinib—ERBB4—Disease—EGFR—chronic obstructive pulmonary disease	1.3e-05	0.000127	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.28e-05	0.000125	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.27e-05	0.000124	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.26e-05	0.000124	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.26e-05	0.000123	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.24e-05	0.000122	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.23e-05	0.00012	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS2—chronic obstructive pulmonary disease	1.22e-05	0.00012	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.22e-05	0.000119	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.22e-05	0.000119	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.2e-05	0.000117	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.19e-05	0.000117	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.17e-05	0.000114	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.14e-05	0.000112	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.13e-05	0.00011	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.13e-05	0.00011	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.12e-05	0.000109	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.11e-05	0.000108	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL6—chronic obstructive pulmonary disease	1.1e-05	0.000107	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.1e-05	0.000107	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.08e-05	0.000106	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL6—chronic obstructive pulmonary disease	1.08e-05	0.000106	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.07e-05	0.000105	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.06e-05	0.000103	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.05e-05	0.000102	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.03e-05	0.000101	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.03e-05	0.000101	CbGpPWpGaD
Lapatinib—EGFR—Disease—SERPINE1—chronic obstructive pulmonary disease	1.03e-05	0.000101	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.03e-05	0.0001	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.03e-05	0.0001	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IL6—chronic obstructive pulmonary disease	1.01e-05	9.91e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.01e-05	9.88e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.01e-05	9.87e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1e-05	9.77e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IL6—chronic obstructive pulmonary disease	9.98e-06	9.76e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.89e-06	9.66e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS3—chronic obstructive pulmonary disease	9.83e-06	9.61e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.78e-06	9.56e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.72e-06	9.51e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.59e-06	9.37e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.55e-06	9.33e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.42e-06	9.21e-05	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.28e-06	9.07e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.28e-06	9.07e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.23e-06	9.03e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.19e-06	8.98e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6—chronic obstructive pulmonary disease	9.11e-06	8.91e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.1e-06	8.89e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1B—chronic obstructive pulmonary disease	9.06e-06	8.86e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.01e-06	8.81e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.94e-06	8.73e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.8e-06	8.6e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.47e-06	8.28e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.42e-06	8.23e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.31e-06	8.12e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.75e-06	7.58e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.74e-06	7.57e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.64e-06	7.47e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.52e-06	7.35e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.41e-06	7.25e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.34e-06	7.17e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.34e-06	7.17e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.24e-06	7.07e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.21e-06	7.05e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.1e-06	6.94e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.99e-06	6.83e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.91e-06	6.75e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.89e-06	6.73e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.74e-06	6.59e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.55e-06	6.4e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.52e-06	6.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TGFB1—chronic obstructive pulmonary disease	6.5e-06	6.36e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.45e-06	6.3e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.39e-06	6.25e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.11e-06	5.97e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.88e-06	5.75e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.81e-06	5.68e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	5.76e-06	5.63e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.52e-06	5.4e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	5.51e-06	5.38e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.42e-06	5.3e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6—chronic obstructive pulmonary disease	5.31e-06	5.19e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	4.99e-06	4.88e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.96e-06	4.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6—chronic obstructive pulmonary disease	4.9e-06	4.79e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.77e-06	4.66e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.55e-06	4.45e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.52e-06	4.42e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.46e-06	4.36e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.45e-06	4.35e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.34e-06	4.25e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.26e-06	4.16e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.16e-06	4.06e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.15e-06	4.06e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.94e-06	3.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.75e-06	3.66e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.43e-06	3.35e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.68e-06	2.62e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.56e-06	2.5e-05	CbGpPWpGaD
